STOCK TITAN

LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cataract and Astigmatism Corrective Surgery

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

LENSAR, Inc. (NASDAQ: LNSR) has announced the acceptance of three posters and one paper for virtual presentations at the Annual Meeting of the American Academy of Ophthalmology (AAO), scheduled for November 13-15, 2020. The paper, titled 'Refractive Outcomes of a Light-Adjustable IOL in Cataract Patients With a History of RK,' will be presented by Dr. James D. Lehmann. The accepted posters include studies on the management of astigmatism during cataract surgery, with presentations by Dr. Seong-Jun Lee and Dr. Vasilios F. Diakonis, available on the AAO meeting portal starting November 11, 2020.

Positive
  • Acceptance of multiple presentations (3 posters, 1 paper) at a prestigious medical conference.
  • Potential to enhance LENSAR's visibility and credibility in the medical community through these presentations.
Negative
  • None.

ORLANDO, Fla.--()--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced that three posters and a paper have been accepted for virtual presentations at the Annual Meeting of the American Academy of Ophthalmology (AAO) being held November 13-15, 2020.

Paper Presentation

Paper title: Refractive Outcomes of a Light-Adjustable IOL in Cataract Patients With a History of RK
Presenter: James D Lehmann, MD, Focal Point Vision, San Antonio, TX
Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

Poster Presentations

Presentation title: Outcome of Arcuate Keratotomy Using Iris Registration–Guided Femtosecond Laser for the Management of Astigmatism During Cataract Surgery
Presenter: Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea
Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

Presentation title: Outcome of Toric IOLs Aligned With Iris Registration-Guided, FsL-Assisted Capsular Marks for the Management of Astigmatism During Cataract Surgery
Presenter: Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea
Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

Presentation title: Femtosecond Laser-Assisted Capsulotomy With Capsular Marks for Guiding Toric IOL Alignment During Cataract Surgery
Presenter: Vasilios F Diakonis, MD, PHD, The Eye Institute of West Florida, Largo, FL
Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Contacts

Thomas R. Staab, II, CFO
ir.contact@lensar.com

Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com

FAQ

What presentations will LENSAR showcase at the AAO 2020?

LENSAR will showcase three posters and one paper focused on cataract surgery and astigmatism management at the AAO 2020.

When will the LENSAR presentations be available to view?

The LENSAR presentations will be available starting November 11, 2020, on the AAO meeting portal.

Who is presenting the paper at the AAO meeting for LENSAR?

Dr. James D. Lehmann will present the paper titled 'Refractive Outcomes of a Light-Adjustable IOL in Cataract Patients With a History of RK.'

What is the significance of LENSAR's participation in the AAO 2020?

LENSAR's participation highlights its commitment to advancing cataract surgery technology and enhancing its reputation in the ophthalmology field.

LENSAR, Inc.

NASDAQ:LNSR

LNSR Rankings

LNSR Latest News

LNSR Stock Data

85.37M
9.31M
19.57%
42.43%
0.43%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ORLANDO